Skip to content

Study on the correlation between changes in vascular permeability and miR-202-5p/MARCH6 in elderly ARDS patients

Study on the correlation between changes in vascular permeability and miR-202-5p/MARCH6 in elderly ARDS patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098693
Enrollment
Unknown
Registered
2025-03-12
Start date
2022-11-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Interventions

Severe pneumonia complicated with ARDS group:Extract peripheral blood and bronchoalveolar lavage fluid
Severe pneumonia without concurrent ARDS group:Extract peripheral blood and bronchoalveolar lavage fluid
Non severe pneumonia group:Extract peripheral blood and bronchoalveolar lavage fluid

Sponsors

Jing'an District Central Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Select elderly pneumonia patients admitted to the ICU of our hospital from October 2022 to September 2024; (2) Age >= 65 years old (according to WHO standards for developed countries); (3) According to the diagnostic criteria for severe pneumonia (CAP) by the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) in 2007; (4) According to the 2012 Berlin definition as the diagnostic criteria for ARDS; (5) I have not used any drugs that have an impact on the measurement indicators of this study in the past three months, such as antibiotics, hormones, immunosuppressants, etc; (6) Number of cases: 180 elderly patients with pneumonia;

Exclusion criteria

Exclusion criteria: (1) There is clear objective evidence of heart failure during the onset of respiratory failure; (2) Objective evidence of excessive fluid load during the onset of respiratory failure; (3) Exclude pulmonary edema caused by elevated hydrostatic pressure; (4) Patients with serious diseases such as chronic infections, immune system, cardiovascular system, central system, respiratory system, coagulation system, liver and kidney function, gastrointestinal dysfunction, etc. in the past 3 months; (5) Patients who died within one week of admission;

Design outcomes

Primary

MeasureTime frame
microRNA-202-5p;MARCH6;angiopoietin-2;intercellular adhesion molecule-1;vascular endothelial growth factor;von willebrand factor;

Countries

the People's Republic of China

Contacts

Public Contactxian JIN

Jing'an District Central Hospital, Shanghai

jinxian777@qq.com+86 137 0199 5548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026